-
Product Insights
NewE Selectin – Drugs In Development, 2024
The E Selectin pipeline drugs market research report outlays comprehensive information on the E Selectin targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Oncology, Hematological Disorders, and Gastrointestinal which include indications of Critical Limb Ischemia, Atherosclerosis, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Metastatic Lung Cancer, Sickle Cell Disease With Vaso-Occlusive Crisis, and Hepatic Injury. It...
-
Product Insights
NewProstaglandin E Synthase – Drugs In Development, 2024
The Prostaglandin E Synthase pipeline drugs market research report outlays comprehensive information on the Prostaglandin E Synthase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Women's Health, Immunology, and Gastrointestinal which include indications of Pain, Amyotrophic Lateral Sclerosis, Endometriosis, Inflammation, Systemic Sclerosis (Scleroderma), Inflammatory Bowel Disease, and Gastritis. It also reviews key players involved...
-
Product Insights
NewBlood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. GlobalData's Medical Devices sector report, “Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Blood Glucose Meters report provides key information...
-
Sector Analysis
NewSweden Cards and Payments – Opportunities and Risks to 2028
Sweden Cards and Payments Market Report Overview The annual value of card transactions in the Sweden cards and payments market was $127.7 billion in 2023 and will grow at a CAGR of more than 6% during 2024-2028. The Sweden cards and payments market research report provides a detailed analysis of market trends in Sweden’s cards and payments industry. It provides values and volumes for key performance indicators in the industry, including cash, cards, credit transfers, and direct debits during the...
-
Sector Analysis
NewAmyotrophic Lateral Sclerosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2029
Amyotrophic Lateral Sclerosis Market Report Overview Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a severely debilitating, rare, and ultimately fatal neurodegenerative condition caused by a combination of genetic and environmental factors. However, the causative pathogenic mechanisms in ALS remain unclear. The condition is characterized by progressive degeneration of both upper (UMNs) and lower motor (LMNs) neurons that leads to death, frequently from respiratory failure, within a few years. The 8MM includes the US, France, Germany,...
-
Sector Analysis
NewWine Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Wine Market Report Overview The wine market size was valued at $333.7 billion in 2023 and will achieve a CAGR of more than 6% during 2023-2028. The increasing popularity of wine among young consumers will drive market growth during the forecast period. The market growth can also be attributed to the increasing investments by wine companies to improve their technological capabilities to serve consumers better and make wines more disease-resistant. Wine Market Outlook 2023-2028 (USD Billion) Buy the Full Report...
-
Sector Analysis
NewArgentina Cards and Payments – Opportunities and Risks to 2028
Argentina Cards and Payments Market Report Overview The annual value of card transactions in the Argentina cards and payments market was $253.49 billion in 2023 and will grow at a CAGR of more than 68% during 2024-2028. Although cash is the preferred method of payment, there has been a rise in card payments in Argentina. This has been supported by the government’s efforts to boost electronic payments. Argentina Card Transactions Outlook, 2023-2028 ($ Billion) Buy the Full Report for More...
-
Company Insights
NewUnilever – Digital Transformation Strategies
Unilever Digital Transformation Strategies Report Overview Unilever has been focusing on using artificial intelligence, cloud-based mobile applications, big data, and blockchain to digitally transform its operations. The annual ICT spending of Unilever was estimated at $990.3 million for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. Unilever is a manufacturer and supplier of fast-moving consumer goods. The company's product portfolio comprises food, beauty, personal care, beverages, home care, vitamins, minerals,...
-
Sector Analysis
NewRomania Cards and Payments – Opportunities and Risks to 2028
Romania Cards and Payments Market Report Overview The annual value of card transactions in the Romania cards and payments market was $62.2 billion in 2023 and will grow at a CAGR of more than 12% during 2024-2028. Romania is a cash-dominated market. However, cash usage will continue to decline over the forecast period amid the growing preference for electronic payments and the country’s improving payment infrastructure. Romania Card Transactions Outlook, 2023-2028 ($ Billion) Buy the Full Report for More Information...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBRC-101 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBRC-101 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBRC-101 in Solid Tumor Drug Details: MBRC-101 is under development for...